This report, which has been published every two years since 1984, has been updated to 2016. Amounting to $1.5 billion in 1984, $4.8 billion in 1996 and $5.1 billion in 2003, the global market reached $19.7 billion in 2014, or $27.3 billion when including recombinant proteins. The market continues to expand, particularly in emerging markets, and as a result of growing sales of proteins that were not promoted in the past. For each major plasma-derived and recombinant product, sales volumes in dollars and units are provided by region and company. Price trends over the last ten years are also provided. Data for the following products are provided:
- Polyvalent Intravenous and Subcutaneous Immune Globulins
- Hyperimmune Immune Globulins
- Factor VIII (plasma & recombinant)
- Factor IX (plasma & recombinant)
- von Willebrand Factor Complex
- Prothrombin Complex
- Antithrombin III
- Alpha-1 Antitrypsin
- Fibrin Glue
- Other Plasma-derived Products
The data are broken down by region (Asia & Pacific, Central & South America, Europe, Middle East, North America and Oceania) and by company.
The report is delivered electronically (Excel and pdf files) and as a hard copy. For more information or to order this report, please contact The Marketing Research Bureau at email@example.com, or +1 203 799-0298. Individual sections of the report (e.g. a product or region) can be purchased separately.